The devices — Trilogy 100, Trilogy 200, and Garbin Plus ventilators — were recalled because foam could break away from the plastic backing and block the airpath. Patients can also ingest the foam. Both issues can cause serious injury or death, the FDA said Feb. 16.
As of Jan. 4, 82 medical device reporting complaints were filed. There have been no deaths reported.
Philips has temporarily paused reworking the Trilogy 100 and Trilogy 200 ventilators, according to the FDA.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
